Cibus, Inc. (NASDAQ:CBUS) Shares Bought by Renaissance Technologies LLC

Renaissance Technologies LLC raised its position in Cibus, Inc. (NASDAQ:CBUS - Free Report) by 933.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 127,100 shares of the company's stock after acquiring an additional 114,800 shares during the period. Renaissance Technologies LLC owned approximately 0.48% of Cibus worth $353,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CBUS. Geode Capital Management LLC boosted its holdings in shares of Cibus by 7.5% in the 4th quarter. Geode Capital Management LLC now owns 392,387 shares of the company's stock valued at $1,091,000 after acquiring an additional 27,464 shares during the last quarter. Certior Financial Group LLC acquired a new position in shares of Cibus in the fourth quarter worth about $236,000. Raymond James Financial Inc. acquired a new stake in shares of Cibus during the 4th quarter valued at about $89,000. Commonwealth Equity Services LLC purchased a new position in Cibus during the fourth quarter worth approximately $62,000. Finally, Barclays PLC raised its stake in shares of Cibus by 287.2% during the 3rd quarter. Barclays PLC now owns 20,269 shares of the company's stock worth $66,000 after buying an additional 15,034 shares during the period. Hedge funds and other institutional investors own 33.81% of the company's stock.

Analyst Ratings Changes

CBUS has been the topic of a number of research reports. HC Wainwright reaffirmed a "buy" rating and issued a $25.00 price target on shares of Cibus in a research note on Friday, March 21st. Canaccord Genuity Group dropped their price target on Cibus from $20.00 to $18.00 and set a "buy" rating for the company in a research report on Wednesday, January 22nd.

Cibus Trading Down 9.4 %

NASDAQ:CBUS traded down $0.22 during midday trading on Friday, reaching $2.13. The company had a trading volume of 60,160 shares, compared to its average volume of 174,452. The stock's fifty day simple moving average is $1.98 and its 200-day simple moving average is $2.84. Cibus, Inc. has a 12-month low of $1.40 and a 12-month high of $19.56. The firm has a market capitalization of $69.97 million, a price-to-earnings ratio of -0.09 and a beta of 1.70.

Cibus (NASDAQ:CBUS - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($0.08). Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. As a group, sell-side analysts expect that Cibus, Inc. will post -2.96 EPS for the current year.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.